(Q42459821)

1 November 2017

title

Renal dopamine D(1) receptor dysfunction is acquired and not inherited in obese Zucker rats (English)

1 reference

1 November 2017

0 references

Anees Ahmad Banday

1

1 reference

1 November 2017

Tahir Hussain

series ordinal

2

1 reference

1 November 2017

Mustafa F Lokhandwala

series ordinal

3

1 reference

1 November 2017

publication date

6 April 2004

1 reference

American Journal of Physiology - Renal Physiology

1 November 2017

published in

1 reference

1 November 2017

volume

287

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

F109-16

1 reference

Dopamine-Mediated Inhibition of Renal Na,K-ATPase Is Reduced by Insulin

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

G protein-coupled receptor kinase 4 gene variants in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Altered pressure-natriuresis in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

The kidney, hypertension, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Obesity-associated hypertension and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Dopamine fails to inhibit Na,H-exchanger in proximal tubules of obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Renal dopamine receptor function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Genetics of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

The Zucker fatty rat as a genetic model of obesity and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

UCP3 gene expression does not correlate with muscle oxidation rates in troglitazone-treated Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Leptin receptor missense mutation in the fatty Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Dopamine-sodium relationship in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Regulation of the Na+/K+-ATPase by insulin: why and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Significance of exaggerated natriuresis after angiotensin AT1 receptor blockade or angiotensin- converting enzyme inhibition in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00396.2003

10.1152/AJPRENAL.00396.2003

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference